date,title,source
Oct-30-18,"G1 Therapeutics to Provide Third Quarter 2018 Corporate and Financial Update on November 7, 2018",GlobeNewswire
Nov-06-18,G1 Therapeutics to Present at Investor Conferences in November 2018,GlobeNewswire
Nov-07-18,G1 Therapeutics Reports Third Quarter 2018 Financial Results and Corporate Update,GlobeNewswire
Nov-08-18,Edited Transcript of GTHX.O earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-09-18,G1 Therapeutics to Present Preliminary Data from Randomized Phase 2 Trial of Trilaciclib in Metastatic Triple-Negative Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS),GlobeNewswire
Nov-19-18,Edited Transcript of GTHX.O earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-21-18,Edited Transcript of GTHX.O earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",Benzinga
Dec-04-18,Preliminary Results from Randomized Phase 2 Trial Demonstrate Trilaciclib Improved Progression-Free Survival in Combination with Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer,GlobeNewswire
Dec-06-18,"New Research Coverage Highlights G1 THERAPEUTICS, Schlumberger, Adient, Camping World, Nutanix, and CNH Industrial N.V  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Dec-19-18,G1 Therapeutics stock dives on cancer-related infection drug study results,MarketWatch
Dec-19-18,G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Showing Multi-Lineage Myelopreservation Benefits in 2nd-/3rd-Line Small Cell Lung Cancer,GlobeNewswire
Dec-20-18,Why G1 Therapeutics Got Hammered 42.6% Today,Motley Fool
Dec-20-18,"G1 Therapeutics Investors Recoil, Analysts Bullish In Wake Of Trilaciclib Results",Benzinga
Dec-21-18,Raymond James Keeps Bullish View on Biotech G1 After 43% Slide,Bloomberg
Dec-27-18,Stocks down in December for pharma firms in the Triangle,American City Business Journals
Dec-27-18,G1 Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-03-19,From Iqvia to Red Hat: These execs raked in millions from stock sales in 2018,American City Business Journals
Jan-07-19,G1 THERAPEUTICS Enters Oversold Territory,Zacks
Jan-23-19,5 Domestic Stocks to Gain From Thaw in Trade Talks,Zacks
Feb-11-19,"Are Insiders Selling G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock?",Simply Wall St.
Feb-20-19,"Glancy Prongay & Murray LLP Continues Investigation on Behalf of G1 Therapeutics, Inc. Investors (GTHX)",GlobeNewswire
Feb-21-19,"G1 Therapeutics to Report Fourth Quarter and Full-Year 2018 Financial Results on February 28, 2019",GlobeNewswire
Feb-27-19,"G1 Therapeutics to Host Investor Day 2019 on March 6, 2019",GlobeNewswire
Feb-28-19,"G1 Therapeutics, Inc. (GTHX) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Feb-28-19,G1 Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results,GlobeNewswire
Mar-04-19,G1 Therapeutics to Present at Cowen and Company 39th Annual Healthcare Conference,GlobeNewswire
Mar-05-19,Edited Transcript of GTHX.O earnings conference call or presentation 28-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Apr-02-19,G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference,GlobeNewswire
Apr-29-19,G1 Therapeutics stock rallies 25%; company to file application for new cancer drug,MarketWatch
Apr-30-19,Why G1 Therapeutics Is Soaring 16% Today,Motley Fool
Apr-30-19,G1 Therapeutics Hits Its Highest Level Of 2019: What You Need To Know,Benzinga
Apr-30-19,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",Benzinga
May-01-19,G1 Therapeutics to grow as it approaches filing NDA,American City Business Journals
May-02-19,"G1 Therapeutics to Report First Quarter Financial Results on May 9, 2019",GlobeNewswire
May-09-19,G1 Therapeutics Provides First Quarter 2019 Corporate and Financial Update,GlobeNewswire
May-13-19,"G1 Therapeutics, Inc. (GTHX) Q1 2019 Earnings Call Transcript",Motley Fool
May-13-19,G1 Therapeutics to Present at UBS Global Healthcare Conference,GlobeNewswire
May-15-19,Edited Transcript of GTHX.O earnings conference call or presentation 9-May-19 8:30pm GMT,Thomson Reuters StreetEvents
May-16-19,G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting,GlobeNewswire
Jun-11-19,G1 Therapeutics to Present at Raymond James Life Sciences and MedTech Conference,GlobeNewswire
Jun-13-19,G1 Therapeutics Announces Updates to Board of Directors,GlobeNewswire
Jun-14-19,G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting,GlobeNewswire
Jun-18-19,"Why SunPower, Snap, and G1 Therapeutics Jumped Today",Motley Fool
Jun-18-19,What's Behind The Rally In Small-Cap Biotech G1 Therapeutics?,Benzinga
Jun-18-19,G1 Therapeutics Announces Updated Results from Phase 2 Trial of Trilaciclib in Combination with Chemotherapy Showed Statistically Significant Improvement in Overall Survival in Women with Metastatic Triple-Negative Breast Cancer,GlobeNewswire
Jun-19-19,Harry Boxers three biotech stocks on the move include Nektar Therapeutics,MarketWatch
Jun-19-19,Why new cancer trial data is good news for a Triangle pharma,American City Business Journals
Jun-19-19,"Company News For Jun 19, 2019",Zacks
